NASDAQ: ZVRAZevra Therapeutics Inc Stock Ownership - Who owns Zevra Therapeutics?
Insider buying vs selling
Have Zevra Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Neil F. McFarlane | President and CEO | 2025-10-10 | 19,500 | $10.82 | $210.91kSell |
| Tamara A. Favorito | Director | 2025-09-12 | 3,175 | $7.79 | $24.72kBuy |
| Alvin Shih | Director | 2025-09-12 | 20,000 | $7.89 | $157.80kBuy |
| John B. Bode | Director | 2025-08-19 | 5,000 | $9.17 | $45.82kBuy |
| Rahsaan Thompson | Chief Legal Compliance | 2025-06-26 | 24,000 | $9.21 | $221.02kSell |
| Corey Michael Watton | Director | 2025-03-28 | 300 | $7.84 | $2.35kBuy |
| John B. Bode | Director | 2025-03-19 | 10,000 | $7.96 | $79.62kBuy |
| Neil F. McFarlane | President and CEO | 2025-02-14 | 30,544 | $8.05 | $245.97kSell |
| Timothy J. Sangiovanni | SVP Finance Corp Controller | 2025-02-13 | 3,000 | $7.86 | $23.59kSell |
| Joshua Schafer | CCO EVP Bus. Development | 2025-02-13 | 10,500 | $7.86 | $82.53kSell |
ZVRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ZVRA insiders and whales buy or sell their stock.
ZVRA Shareholders
What type of owners hold Zevra Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Woodline Partners LP | 8.22% | 4,615,676 | $48.97M | Institution |
| Adage Capital Partners GP LLC | 7.42% | 4,168,000 | $44.22M | Institution |
| Delaware Street Capital Master Fund LP | 7.30% | 4,095,914 | $43.46M | Insider |
| Blackrock Inc | 7.27% | 4,081,544 | $43.31M | Institution |
| Samuel J. Braun | 5.60% | 3,143,000 | $33.35M | Insider |
| Vanguard Group Inc | 5.26% | 2,952,686 | $31.33M | Institution |
| Christal M. M. Mickle | 4.79% | 2,690,545 | $28.55M | Insider |
| Fmr LLC | 4.08% | 2,289,243 | $24.29M | Institution |
| Rubric Capital Management LP | 3.49% | 1,958,318 | $20.78M | Institution |
| Nantahala Capital Management LLC | 2.62% | 1,471,936 | $15.62M | Institution |
ZVRA vs Biotech Stocks
Zevra Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.